{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-021107","form_type":"8-K","ticker":"AMRX","cik":"0001723128","company_name":"Amneal Pharmaceuticals, Inc.","filed_at":"2024-05-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.746288+00:00","generated_at":"2026-06-02T19:13:16.795134+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Amneal shareholders elect all 11 directors, approve say-on-pay at annual meeting","bullets":["All 11 director nominees elected; votes ranged from 238.7M (Meister) to 254.4M (Yanai) for.","Advisory vote on NEO compensation approved with 254.4M for, 1.2M against.","Ratification of Ernst & Young as auditor for FY2024 passed with 279.1M for, 0.6M against.","Broker non-votes of ~24.1M shares on director election and say-on-pay proposals."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-021107","json":"https://secwatch.observer/filing/0001628280-24-021107.json","markdown":"https://secwatch.observer/filing/0001628280-24-021107.md","text":"https://secwatch.observer/filing/0001628280-24-021107.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024021107/0001628280-24-021107-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024021107/amrx-20240502.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T19:13:16.795134+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"277962e124eb6b4f1819d74a37dfe7243a280897","claim":"Amneal Pharmaceuticals, Inc. shareholders approved To ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024 at the 2024-05-02 meeting.","evidence_excerpt":"Proposal 3 : To ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024: For Against Abstain Broker Non-Votes 279,106,284 624,760 38,456 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024021107/0001628280-24-021107-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2024-05-02"}]},{"claim_id":"8879667017bea3cb1225cc446d8052e951b037cd","claim":"Amneal Pharmaceuticals, Inc. shareholders approved Election of director nominees to hold office until the 2025 Annual Meeting of Stockholders at the 2024-05-02 meeting.","evidence_excerpt":"Proposal 1 : To elect the following director nominees to hold office until the 2025 Annual Meeting of Stockholders and until their respective successors are elected and qualified: For Against Abstain Broker Non-Votes Emily Peterson Alva 253,927,467 1,736,375 40,449 24,065,209","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024021107/0001628280-24-021107-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2024-05-02"}]},{"claim_id":"e8d57777d1aaa6ba24bdb9c46b35721db7b405ad","claim":"Amneal Pharmaceuticals, Inc. shareholders approved To approve, on a non-binding, advisory basis, the compensation of the Company’s named executive officers at the 2024-05-02 meeting.","evidence_excerpt":"Proposal 2 : To approve, on a non-binding, advisory basis, the compensation of the Company’s named executive officers: For Against Abstain Broker Non-Votes 254,365,134 1,199,935 139,222 24,065,209","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024021107/0001628280-24-021107-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2024-05-02"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}